Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
29 Oct 2021  |  North America  |  Market Research
US 5G Wireless Growth Opportunities in Healthcare
Advances in Network Capabilities Liberate Remote Patient Monitoring, Telehealth, and Virtual Care from Yesterday’s Limitations
5G refers to the 5th generation of wireless technology that promises to deliver game-changing benefits to users, including dramatically increased bandwidth, higher speed, reduced latency, and network slicing. The bottom line: 5G will accommodate dramatically more devices, media, and users. This will especially impact the Internet of Things, which w...
$2,450.00 -
26 Oct 2021  |  Global  |  Customer Research
Hybrid and Multicloud Healthcare IT Transformation
Findings from the 2020 Frost & Sullivan Global Cloud User Survey
Healthcare providers are accelerating digitization strategies due to the COVID-19 pandemic. The most successful providers leverage cloud computing to meet business agility, cost savings, innovation, data storage, security, and privacy goals. Frost & Sullivan conducted the 2020 Global Cloud User Survey between August and September 2020 in North A...
$4,950.00 -
14 Oct 2021  |  North America  |  Market Research
US Healthcare Cybersecurity Growth Opportunities
Increased Adoption by End Users and a Growing Number of New Entrants Catalyzing Transformational Growth
The research service will provide an overview of the US healthcare cybersecurity market from 2021 to 2026. Healthcare cybersecurity includes those systems, applications, and IT-enabled services that assess third-party vendor risks, safeguard data networks, privatize cloud-based access management, and ensure the state-of-the-art security of all IT s...
$2,450.00 -
23 Jul 2021  |  North America  |  Market Research
US Digital Therapeutics Growth Opportunities
Transformational Growth in New Business Models After COVID-19
Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...
$4,950.00 -
07 Jul 2021  |  North America  |  Market Research
United States Healthcare Consumerism Growth Opportunities
The Quantified Self Consumer Behavior and Innovative Business Models Create Future Growth Potential
This research service examines the future of healthcare consumerism in the United States in terms of changing patient demographics and demands, technological advancements, digital health, shift in consumer behavior to non-traditional healthcare settings, and innovative healthcare business models. Healthcare consumerism is on the rise as individual...
$2,450.00 -
06 Jul 2021  |  North America  |  Market Research
Global Digital Health Solutions for Behavioral Health Management Growth Opportunities
Novel Business Models Supported by Virtual Care Technologies that Offer Direct Patient Support will Emerge Over the Next 2-3 Years
The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”. Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health. Mass unemployment, salary reductions, depleting financial security ...
$4,950.00 -
01 Jun 2021  |  North America  |  Frost Radar
Frost Radar™: US Population Health Management Market, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...
$4,950.00 -
21 May 2021  |  North America  |  Market Research
Explosion of Data Drives the US Social Determinants of Health Market
Proven Returns on Investment will Ignite Transformational Growth
This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...
$2,450.00 -
09 Feb 2021  |  North America  |  Market Research
COVID-19 Pandemic Ignites Enthusiasm for Virtual Care
Competitors’ Growth Strategies will Shape the Way the Market Opportunity Crystallizes
There is no one definition for virtual care, but Frost & Sullivan defines it in this research as a technical platform that maintains an interactive connectivity between patients, providers, and payers where various processes and services may be scheduled, accessed, monitored, and entered into the medical record without the need for manual calls or ...
$4,950.00 -
08 Nov 2018  |  North America  |  Market Research
US Population Health Management Market, Forecast to 2022
How PHM 2.0 Symbolizes Precision Health
Frost & Sullivan announces exciting new research from its Transformational Health program touching on some of the most important issues in healthcare now and in the future. This Frost & Sullivan research service presents a comprehensive analysis of the market potential and dynamics of the population health management (PHM) market in the United S...
$4,950.00